In contrast to systemic anaplastic large-cell lymphoma (sALCL), the cases of ALK+ pcALCL seem to have a favorable outcome, comparable to that of patients with ALK- pcALCL. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.